Does Locoregional Chemotherapy Still Matter in the Treatment of Advanced Pelvic Melanoma?

Pelvic Melanoma relapse occurs in 15% of patients with loco regional metastases, and 25% of cases do not respond to new target-therapy and/or immunotherapy. Melphalan hypoxic pelvic perfusion may, therefore, be an option for these non-responsive patients. Overall median survival time (MST), stratifi...

Full description

Saved in:
Bibliographic Details
Published in:Int J Mol Sci
Main Authors: Guadagni, Stefano, Fiorentini, Giammaria, Clementi, Marco, Palumbo, Giancarlo, Palumbo, Paola, Chiominto, Alessandro, Baldoni, Stefano, Masedu, Francesco, Valenti, Marco, Di Tommaso, Ambra, Fabi, Bianca, Aliberti, Camillo, Sarti, Donatella, Guadagni, Veronica, Pellegrini, Cristina
Format: Artigo
Language:Inglês
Published: MDPI 2017
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5713351/
https://ncbi.nlm.nih.gov/pubmed/29120401
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18112382
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items